Page last updated: 2024-09-04

atazanavir sulfate and Disease Models, Animal

atazanavir sulfate has been researched along with Disease Models, Animal in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ji, Y; Jiang, W; Li, B; Li, D; Song, S; Zhang, G; Zhang, X1
Chmielinska, JJ; ElZohary, L; Kramer, JH; Mak, IT; Weglicki, WB1
Ciurlionis, R; Degoey, DA; Kempf, DJ; Klein, LL; Marsh, K; Randolph, JT; Spear, B; Waring, JF1
Andrews, S; Carlson, GA; Hanamsagar, R; Huang, Y; Ikezu, T; Kiyota, T; Lan, X; Peng, H; Swindells, S; Zheng, JC1
Hruz, PW; Jay, PY; Struthers, H; Yan, Q1

Other Studies

5 other study(ies) available for atazanavir sulfate and Disease Models, Animal

ArticleYear
Protective Effect of Atazanavir Sulphate Against Pulmonary Fibrosis In Vivo and In Vitro.
    Basic & clinical pharmacology & toxicology, 2018, Volume: 122, Issue:2

    Topics: A549 Cells; Animals; Atazanavir Sulfate; Bleomycin; Cell Proliferation; Collagen; Cytoprotection; Disease Models, Animal; Epithelial Cells; Epithelial-Mesenchymal Transition; Fibroblasts; HMGB1 Protein; Humans; Lung; Male; Pulmonary Fibrosis; Rats, Sprague-Dawley; Signal Transduction; Toll-Like Receptors

2018
Mg-supplementation attenuated lipogenic and oxidative/nitrosative gene expression caused by Combination Antiretroviral Therapy (cART) in HIV-1-transgenic rats.
    PloS one, 2019, Volume: 14, Issue:1

    Topics: Animals; Anti-Retroviral Agents; Atazanavir Sulfate; Dietary Supplements; Disease Models, Animal; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Gene Expression Regulation; HIV Infections; HIV-1; Humans; Lipogenesis; Liver; Magnesium; Male; NF-E2-Related Factor 2; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Inbred F344; Rats, Transgenic; Ritonavir

2019
Identification of proteasome gene regulation in a rat model for HIV protease inhibitor-induced hyperlipidemia.
    Archives of toxicology, 2010, Volume: 84, Issue:4

    Topics: Animals; Atazanavir Sulfate; Carbamates; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Furans; Gene Expression Profiling; Gene Expression Regulation, Enzymologic; HIV Protease Inhibitors; Hyperlipidemias; Male; Oligonucleotide Array Sequence Analysis; Oligopeptides; Proteasome Endopeptidase Complex; Pyridines; Rats; Rats, Sprague-Dawley; Ritonavir; Sulfonamides

2010
The effect of HIV protease inhibitors on amyloid-β peptide degradation and synthesis in human cells and Alzheimer's disease animal model.
    Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2012, Volume: 7, Issue:2

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Atazanavir Sulfate; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; HIV Protease Inhibitors; Humans; Immunoblotting; Immunohistochemistry; Lopinavir; Macrophages; Mice; Mice, SCID; Mice, Transgenic; Nelfinavir; Neurons; Oligopeptides; Pyridines; Ritonavir; Saquinavir

2012
HIV protease inhibitors that block GLUT4 precipitate acute, decompensated heart failure in a mouse model of dilated cardiomyopathy.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2008, Volume: 22, Issue:7

    Topics: Animals; Atazanavir Sulfate; Blood Glucose; Cardiomyopathy, Dilated; Deoxyglucose; Disease Models, Animal; Echocardiography; Glucose Tolerance Test; Glucose Transporter Type 4; Heart Failure; HIV Protease Inhibitors; Humans; Insulin Resistance; Lopinavir; Mice; Myocardium; Oligopeptides; Pulmonary Edema; Pyridines; Pyrimidinones

2008